| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.08 |